SCHEMBL24742277

SCHEMBL24742277

CN(CCCNC(=O)OC(C)(C)C)Cc1cc(C(F)(F)F)cc(Br)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 6/20 0.41
▸ TMEM97 Q5BJF2 5/20 0.41
▸ CACNA1B Q00975 2/20 0.41
▸ CACNA1C Q13936 2/20 0.41
▸ CACNA1H O95180 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ STK17B O94768 1/20 0.37
▸ STK17A Q9UEE5 1/20 0.37
▸ CACNA1G O43497 1/20 0.36
▸ CKS1B P61024 1/20 0.36
▸ SKP1 P63208 1/20 0.36
▸ SKP2 Q13309 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.35
▸ P2RY14 Q15391 1/20 0.35
▸ NR1H2 P55055 1/20 0.34
▸ NR1H3 Q13133 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24743067 0.82 CKS1B (0.42) SIGMAR1TMEM97TDP1STK17BSTK17A
SCHEMBL12874037 0.73 CACNA1H (0.45) CACNA1BCACNA1CCACNA1HTDP1STK17B
SCHEMBL1186965 0.73 CACNA1H (0.45) CACNA1BCACNA1CCACNA1HTDP1STK17B
SCHEMBL31687500 0.73 SIGMAR1 (0.58) SIGMAR1TMEM97TDP1MEN1KMT2A
SCHEMBL13377000 0.72 TDP1 (0.66) TDP1STK17BSTK17ACKS1BSKP1
SCHEMBL25963691 0.71 TDP1 (0.64) TDP1STK17BSTK17ACKS1BSKP1
SCHEMBL31687499 0.71 SIGMAR1 (0.58) SIGMAR1TMEM97TDP1MEN1GAA
SCHEMBL4600182 0.70 SIGMAR1 (0.62) SIGMAR1TMEM97
SCHEMBL31239022 0.70 CACNA1B (0.42) CACNA1BCACNA1CCACNA1HCACNA1GGAA
SCHEMBL31687519 0.70 ACKR3 (0.57) SIGMAR1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022206888-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2022-10-06 — — WO disclosed
Send feedback